North America Sleep Disorder Treatment Market is growing with factors such as increased prevalence of sleep disorders such as sleep apnea, insomnia and narcolepsy among others along with the technological advancements in the sleep disorder treatment market.
However, the high cost of devices of sleep disorder treatment along with the side-effects associated with the sleep disorder drugs may obstruct the growth of the market in the given forecast period.
North America Sleep Disorder Treatment Market Scenario
According to Data Bridge Market Research, the market for sleep disorder treatment market in the U.S. has the highest market share followed by Canada and Mexico. Market leader is Jazz Pharmaceuticals, Inc. which accounts an estimated market share of approximately 15% to 20%. The company has gained outstanding sales through providing sleep disorder treatment.
- In September 2020, Jazz Pharmaceuticals plc announced the collaboration with American Heart Association's sleep health educational content in order to strengthen its sleep heath therapeutic area. This new collaboration done by the company has increased its credibility in the market.
Trends Impacting the Market
Now the question is which other regions Jazz Pharmaceuticals, Inc. and Eli Lilly and Company and Viatris Inc. are targeting? Data Bridge Market Research has estimated a large growth in North America Sleep disorder treatment market and the market leaders targeting U.S., Canada and Mexico to be their next revenue pockets for 2020.
The sleep disorder treatment market is becoming more competitive with companies such as Jazz Pharmaceuticals, Inc. and Eli Lilly and Company and Viatris Inc. as they are the market leaders for North America sleep disorder treatment market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the sleep disorder treatment market.
For more analysis on the North America sleep disorder treatment market request for a briefing with our analysts https://www.databridgemarketresearch.com/ru/speak-to-analyst/?dbmr=north-america-sleep-disorder-treatment-market
North America Sleep Disorder Treatment Market Development
- In November 2016, Pfizer, Inc. announced that its division named Upjohn is combined with Mylan N.V. and formed a new company named Viatris. This combination of the business division of the company with Mylan N.V. has increased its product portfolio leading to increased demand for its product in the market.
Scope of the North America Sleep Disorder Treatment Market
North America Sleep disorder treatment market is segmented on the basis of countries into the U.S., Canada, and Mexico.
All country-based analysis of North America sleep disorder treatment market is further analyzed based on further segmentation. On the basis of type, the sleep disorder treatment market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS), narcolepsy and others. On the basis of treatment, the sleep disorder treatment market is segmented into pharmacological therapy, mechanical therapy, mandibular advancement devices, hypoglossal nerve stimulator, surgery and others. On the basis of route of administration, the sleep disorder treatment market is segmented into oral, parenteral and others. On the basis of drugs type, the sleep disorder treatment market is segmented into branded and generics. On the basis of population type, the sleep disorder treatment market is segmented into children and adults. On the basis of end user, the sleep disorder treatment market is segmented into hospitals, specialty clinics, home healthcare, ambulatory surgical center and others. On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
To know more about the study https://www.databridgemarketresearch.com/ru/reports/north-america-sleep-disorder-treatment-market
Key Pointers Covered in North America Sleep Disorder Treatment Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
- Jazz Pharmaceuticals, Inc.
- Pfizer Inc.
- Viatris Inc.
- Arbor Pharmaceuticals
- Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
- sanofi-aventis U.S. LLC (a subsidiary of Sanofi)
- Hikma Pharmaceuticals PLC
- Amneal Pharmaceuticals LLC
- Lupin Pharmaceuticals, Inc. (a subsidiary of Lupin)
- Taj Pharmaceuticals Limited
- Eli Lilly and Company
- Mallinckrodt
- Alembic Pharmaceuticals Limited
- Apotex Inc.
- Dr. Reddy’s Laboratories Ltd.
- Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- Taro Pharmaceutical Industries Ltd.
- Koninklijke Philips N.V.
- DeVilbiss Healthcare LLC
- ResMed
- SomnoMed
- Oventus
- BMC Medical Co.
Above are the key players covered in the report, to know about more and exhaustive list of sleep disorder treatment companies’, contact us https://www.databridgemarketresearch.com/ru/toc/?dbmr=north-america-sleep-disorder-treatment-market
Research Methodology: North America Sleep Disorder Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Sleep Physician, Neurologists, ENT specialists, Rehabilitation Centers, clinicians and technicians, Academic Professionals and Researchers
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/ru/report-category/healthcare/
